Eli Lilly's chief executive, chairman and president John Lechleiter is to step down in December, and will be replaced David Ricks, who currently leads the company’s bio-medicines division.

In early 2018, Dave Ricks, the chief executive of the pharmaceutical giant Eli Lilly, was on a West ... His predecessor, John ...

Eli Lilly has a long, proud history that begins ... In 2009 the company’s then-CEO John Lechleiter and his leadership team ...

Eli Lilly’s CEO David Ricks could sign more ... Ricks has been in post now for two years after taking over from John Lechleiter, and is beginning to make his mark on the company, most notably ...